Take the National Fibromyalgia & Chronic Pain Association Survey, Available Until March 8

Take the National Fibromyalgia & Chronic Pain Association Survey, Available Until March 8
shutterstock_234375976The National Fibromyalgia & Chronic Pain Association is collecting data through an online survey that will remain available until March 8 to evaluate whether hydrocodone (Vicodin, Lorcet, Lortab) being moved from a Schedule III opioid medication to Schedule II under the U.S. Controlled Substances Act has impacted care for those suffering from chronic pain. Being classified as a Schedule II opioid medication means that stricter regulations by the United States Drug Enforcement Administration must be followed by pharmacists and doctors while prescribing and filling these medications. This fact may have significantly changed how hydrocodone is prescribed, and by participating in this survey, the Association can have a clearer picture of how this federal ruling affects medication accessibility. Participation in the survey is entirely voluntary, and there will be no identifying information collected throughout the questionnaire. This is an opportunity to let t
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *